NCT02382640 Effect of Antacid on Bioavailability of Febuxostat After Administration of a Febuxostat 80 mg Extended-Release Capsule Status COMPLETED Phase PHASE1
NCT02381288 Effects of TAK-448 in Middle-aged and Older Men With Low Testosterone Status TERMINATED Phase PHASE2
NCT02379091 Dose Finding Study of Namilumab in Combination With Methotrexate in Participants With Moderate to Severe Rheumatoid Arthritis (RA) Status COMPLETED Phase PHASE2
NCT02372097 A Phase 1, Bioequivalence Study of SYR-472 25mg and 50mg Tablets Status COMPLETED Phase PHASE1
NCT02371980 Vortioxetine, 5, 10, and 20 mg, Relapse Prevention Study in Adults With Major Depressive Disorder (MDD) Status COMPLETED Phase PHASE4
NCT02370615 Drug-Drug Interaction Study Between TAK-272 and Itraconazole, Digoxin or Midazolam Status COMPLETED Phase PHASE1
NCT02370602 An [^11C]T-773 Positron Emission Tomography (PET) Study to Determine Phosphodiesterase10A Occupancy by TAK-063 Status COMPLETED Phase PHASE1
NCT02369796 A Phase 2a Pharmacodynamic Study of TAK-448 in Participants With Hypogonadotropic Hypogonadism Status TERMINATED Phase PHASE2
NCT02367885 Phase 1/2 Study of TAK-850 Intramuscular Injection in Healthy Pediatric Participants Status COMPLETED Phase PHASE1/PHASE2
NCT02367872 Phase I Open-label Study to Evaluate Pharmacokinetics of TAK-272 in Participants With Renal or Hepatic Impairment Status COMPLETED Phase PHASE1
NCT02351960 Dexlansoprazole in Asian Participants With Gastroesophageal Reflux Disease Status COMPLETED Phase PHASE4
NCT02348658 A Phase 1 Food Effect Study of TAK-536TCH Final Formulation Tablet Status COMPLETED Phase PHASE1
NCT02346344 Outpatient Characterization of the Variability of Insulin Secretory Parameters in the Meal Tolerance and the Maximal Stimulation Tests of Subjects With Type 2 Diabetes Mellitus Status COMPLETED Phase N/A
NCT02338713 Effect of Calcium 500 mg and Vitamin D3 1000 IU Chewable Tablet on Intestinal Calcium Absorption Status COMPLETED Phase PHASE1
NCT02337946 Safety and Efficacy Study of mFOLFOX6 + Panitumumab Combination Therapy and 5-FU/LV + Panitumumab Combination Therapy in Participants With Chemotherapy-naïve Unresectable Advanced Recurrent Colorectal Carcinoma Status COMPLETED Phase PHASE2
NCT02337764 A Long-term, Phase 3 Study of TVP-1012 (1 mg) in Levodopa Treated Parkinson's Disease Participants Status COMPLETED Phase PHASE3
NCT02337751 A Phase 3, Long-term, Extension Study of TVP-1012 (1 mg) in Early Parkinson's Disease Participants Status COMPLETED Phase PHASE3